NCT00674115View on ClinicalTrials.gov

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Gastric AcidHuman Experimentation
Interventions
DRUG

Omeprazole/sodium bicarbonate

Omeprazole/sodium bicarbonate. Single dose per day for either 1 or 7 days.

DRUG

omeprazole magnesium

Omeprazole 20 mg tablet. Single dose per day for either 1 or 7 days.

DRUG

sodium bicarbonate

Sodium bicarbonate. Single dose.

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

Bayer

INDUSTRY

NCT00674115 - A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED) | Biotech Hunter | Biotech Hunter